Champions Oncology, Inc.CSBRNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+3.5%
5Y CAGR+9.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+3.5%/yr
vs +22.2%/yr prior
5Y CAGR
+9.7%/yr
Recent deceleration
Acceleration
-18.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$19.12M+25.4%
2025$15.24M-15.9%
2024$18.13M+5.2%
2023$17.24M+11.3%
2022$15.50M+28.8%
2021$12.03M+10.8%
2020$10.86M+40.4%
2019$7.73M+16.5%
2018$6.64M-19.2%
2017$8.22M-